Imjudo 00310-4535
Generic: Tremelimumab
Product NDC
00310-4535- Manufacturer
- Astrazeneca Pharmaceuticals Lp
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 21, 2022
- Listing Expires
- December 31, 2026
- Application
- BLA761289
Need to source Imjudo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tremelimumab | 300 mg/15mL |
Drug Class
CTLA-4-directed Blocking Antibody [EPC]CTLA-4-directed Antibody Interactions [MoA]CTLA-4-directed Blocking Antibody [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (0310-4535-30) / 15 mL in 1 VIAL